Trametinib 3
Contact us: [email protected]
Trametinib (GSK1120212) |
A3018-200 |
ApexBio |
200 mg |
EUR 327.6 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametinib (GSK1120212) |
A3018-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametinib (GSK1120212) |
A3018-50 |
ApexBio |
50 mg |
EUR 193.2 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametinib (GSK1120212) |
A3018-500 |
ApexBio |
500 mg |
EUR 622.8 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametinib (GSK1120212) |
A3018-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametinib DMSO solvate |
A3887-10 |
ApexBio |
10 mg |
EUR 129.6 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametinib DMSO solvate |
A3887-100 |
ApexBio |
100 mg |
EUR 224.4 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametinib DMSO solvate |
A3887-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametinib DMSO solvate |
A3887-50 |
ApexBio |
50 mg |
EUR 170.4 |
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
Trametenolic acid |
TBZ2878 |
ChemNorm |
unit |
Ask for price |
Tram1 3'UTR GFP Stable Cell Line |
TU272384 |
ABM |
1.0 ml |
Ask for price |
TRAM1 3'UTR GFP Stable Cell Line |
TU076281 |
ABM |
1.0 ml |
EUR 1672.8 |
TRAM2 3'UTR GFP Stable Cell Line |
TU076283 |
ABM |
1.0 ml |
EUR 5540.4 |
Tram1 3'UTR GFP Stable Cell Line |
TU171031 |
ABM |
1.0 ml |
Ask for price |
Tram2 3'UTR GFP Stable Cell Line |
TU171033 |
ABM |
1.0 ml |
Ask for price |
Tram1l1 3'UTR GFP Stable Cell Line |
TU272385 |
ABM |
1.0 ml |
Ask for price |
TRAM1L1 3'UTR GFP Stable Cell Line |
TU076282 |
ABM |
1.0 ml |
EUR 1672.8 |
Tram1l1 3'UTR GFP Stable Cell Line |
TU171032 |
ABM |
1.0 ml |
Ask for price |
Tramadol 3 antibody |
20-1511 |
Fitzgerald |
100 ul |
EUR 1054.8 |
Description: Sheep polyclonal Tramadol 3 antibody |
Tram1 3'UTR Luciferase Stable Cell Line |
TU222384 |
ABM |
1.0 ml |
Ask for price |
Tram1 3'UTR Luciferase Stable Cell Line |
TU121031 |
ABM |
1.0 ml |
Ask for price |
Tram2 3'UTR Luciferase Stable Cell Line |
TU121033 |
ABM |
1.0 ml |
Ask for price |
TRAM1 3'UTR Luciferase Stable Cell Line |
TU026281 |
ABM |
1.0 ml |
EUR 1672.8 |
TRAM2 3'UTR Luciferase Stable Cell Line |
TU026283 |
ABM |
1.0 ml |
EUR 5540.4 |
Tram1l1 3'UTR Luciferase Stable Cell Line |
TU222385 |
ABM |
1.0 ml |
Ask for price |
Tram1l1 3'UTR Luciferase Stable Cell Line |
TU121032 |
ABM |
1.0 ml |
Ask for price |
TRAM1L1 3'UTR Luciferase Stable Cell Line |
TU026282 |
ABM |
1.0 ml |
EUR 1672.8 |
Tram1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
K7275804 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Tram1l1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
K6385204 |
ABM |
1.0 ug DNA |
EUR 184.8 |
TRAM1 sgRNA CRISPR Lentivector (Human) (Target 3) |
K2440104 |
ABM |
1.0 ug DNA |
EUR 184.8 |
TRAM2 sgRNA CRISPR Lentivector (Human) (Target 3) |
K2440304 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Tram2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K4015304 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Tram1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K4039104 |
ABM |
1.0 ug DNA |
EUR 184.8 |
TRAM1L1 sgRNA CRISPR Lentivector (Human) (Target 3) |
K2440204 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Tram1l1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K4239504 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Tram1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
K7275808 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Tram1l1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
K6385208 |
ABM |
1.0 ug DNA |
EUR 200.4 |
TRAM1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K2440108 |
ABM |
1.0 ug DNA |
EUR 200.4 |
TRAM2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K2440308 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Tram2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K4015308 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Tram1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K4039108 |
ABM |
1.0 ug DNA |
EUR 200.4 |
TRAM1L1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K2440208 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Tram1l1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K4239508 |
ABM |
1.0 ug DNA |
EUR 200.4 |
TRAM-34 |
A1888-100 |
ApexBio |
100 mg |
EUR 616.8 |
Description: TRAM-34 is a highly selective inhibitor of KCa3.1 channel with IC50 value of 20 nM [1].The Ca (2+)-binding protein calmodulin (CaM) confers Ca (2+) sensitivity to KCa3.1 of KCa3.1. |
TRAM-34 |
A1888-25 |
ApexBio |
25 mg |
EUR 309.6 |
Description: TRAM-34 is a highly selective inhibitor of KCa3.1 channel with IC50 value of 20 nM [1].The Ca (2+)-binding protein calmodulin (CaM) confers Ca (2+) sensitivity to KCa3.1 of KCa3.1. |
TRAM-34 |
A1888-5 |
ApexBio |
5 mg |
EUR 129.6 |
Description: TRAM-34 is a highly selective inhibitor of KCa3.1 channel with IC50 value of 20 nM [1].The Ca (2+)-binding protein calmodulin (CaM) confers Ca (2+) sensitivity to KCa3.1 of KCa3.1. |
TRAM1 siRNA |
20-abx905765 |
Abbexa |
|
|
|
TRAM1 siRNA |
20-abx937930 |
Abbexa |
|
|
|
TRAM1 siRNA |
20-abx937931 |
Abbexa |
|
|
|
TRAM2 siRNA |
20-abx937932 |
Abbexa |
|
|
|
TRAM2 siRNA |
20-abx937933 |
Abbexa |
|
|
|
TRAM1 Rabbit pAb |
A15142-100ul |
Abclonal |
100 ul |
EUR 369.6 |
TRAM1 Rabbit pAb |
A15142-200ul |
Abclonal |
200 ul |
EUR 550.8 |
TRAM1 Rabbit pAb |
A15142-20ul |
Abclonal |
20 ul |
EUR 219.6 |
TRAM1 Rabbit pAb |
A15142-50ul |
Abclonal |
50 ul |
EUR 267.6 |
TRAM1L1 siRNA |
20-abx937928 |
Abbexa |
|
|
|
TRAM1L1 siRNA |
20-abx937929 |
Abbexa |
|
|
|
TRAM1 antibody |
22159-100ul |
SAB |
100ul |
EUR 468 |
TRAM1 antibody |
70R-13203 |
Fitzgerald |
100 ul |
EUR 548.4 |
Description: Affinity purified Rabbit polyclonal TRAM1 antibody |
TRAM2 antibody |
70R-6865 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Rabbit polyclonal TRAM2 antibody raised against the N terminal of TRAM2 |
TRAM1 antibody |
70R-20962 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal TRAM1 antibody |
TRAM2 antibody |
70R-20963 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal TRAM2 antibody |
TRAM2 Antibody |
45248-100ul |
SAB |
100ul |
EUR 302.4 |
TRAM2 Antibody |
45248-50ul |
SAB |
50ul |
EUR 224.4 |
TRAM1 Antibody |
1-CSB-PA024221GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against TRAM1. Recognizes TRAM1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
TRAM2 Antibody |
1-CSB-PA024223GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against TRAM2. Recognizes TRAM2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
TRAM2 Antibody |
1-CSB-PA624011LA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against TRAM2. Recognizes TRAM2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
TRAM2 Antibody |
R31118 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: Translocation-Associating Membrane Protein 2, also called KIAA0057, is a protein that in humans is encoded by the TRAM2 gene. It is a component of the translocon, a gated macromolecular channel that controls the posttranslational processing of nascent secretory and membrane proteins at the endoplasmic reticulum(ER) membrane. By genomic sequence analysis, Onuchic et al.(1999) mapped the gene to chromosome 6p21.1-p12 near the PKHD1 gene. Upon activation, quiescent hepatic stellate cells proliferate, change morphologically into myofibroblasts, and increase their synthesis of extracellular matrix proteins. Stefanovic et al.(2004) demonstrated that both TRAM2 and collagen type I are upregulated in activated rat and human hepatic stellate cells. |
TRAM1L1 antibody |
70R-7050 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Rabbit polyclonal TRAM1L1 antibody raised against the middle region of TRAM1L1 |
anti- TRAM1 antibody |
FNab08926 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against TRAM1 |
anti- TRAM2 antibody |
FNab08927 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against TRAM2 |
anti- tram1 antibody |
FNab10225 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against tram1 |
Tram1 ORF Vector (Rat) (pORF) |
ORF078178 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Trametinib 3